AU Small Finance Bank & ICICI Prudential Life Insurance collaborate for life insurance products
AU Small Finance Bank & ICICI Prudential Life Insurance collaborate for life insurance products

AU Small Finance Bank & ICICI Prudential Life Insurance collaborate for life insurance products

Shreya Chaware Article rating: 3.3

AU Small Finance Bank has informed that it has entered into a strategic partnership with ICICI Prudential Life Insurance Company to offer personalised insurance solutions to enhance the customer experience. The former aims to offer customised & goal-based life insurance solutions. 

Sensex, Nifty on gaining streak; Snowman Logistics jumps 13 per cent, Vedanta declines
Sensex, Nifty on gaining streak; Snowman Logistics jumps 13 per cent, Vedanta declines

Sensex, Nifty on gaining streak; Snowman Logistics jumps 13 per cent, Vedanta declines

Geyatee Deshpande Article rating: 4.7

The domestic benchmark indices continued to hit record highs as investors cheered on positive global & domestic cues. On Tuesday, Sensex gained by 259.33 points or by 0.55 per cent to settle at 47,613.08 levels while Nifty closed up by 59.40 points or 0.43 per cent at 13,932.60 levels.  

Dhanuka Agritech, a probable breakout?
Dhanuka Agritech, a probable breakout?

Dhanuka Agritech, a probable breakout?

Henil Shah Article rating: 3.9

Dhanuka Agritech is probably giving a breakout from a descending triangle chart pattern on the weekly charts. Read on to find out more.

Glenmark pioneers Remogliflozin & Vildagliptin fixed dose for type 2 diabetes
Glenmark pioneers Remogliflozin & Vildagliptin fixed dose for type 2 diabetes

Glenmark pioneers Remogliflozin & Vildagliptin fixed dose for type 2 diabetes

Anthony Fernandes Article rating: 5.0

Glenmark Pharmaceuticals announced on Tuesday that it has launched a fixed-dose combination (FDC) of its novel, patent-protected Sodium-Glucose co-transporter inhibitors (SGLT2i)- Remogliflozin Etabonate and another commonly used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) – Vildagliptin, in India.  

Biocon Biologics to get Biologics licence application for cancer & eye disease medication
Biocon Biologics to get Biologics licence application for cancer & eye disease medication

Biocon Biologics to get Biologics licence application for cancer & eye disease medication

Shreya Chaware Article rating: 3.5

Biocon Biologics Ltd (a subsidiary of Biocon Ltd) and Mylan (a subsidiary of Viatris Inc.) have been further informed by United States Food & Drug Administration (USFDA) regarding the deferral of the action on Biologics licence application (BLA) for MYL-1402O, a proposed biosimilar to Avastin® (Bevacizumab). 

Fund your children education via MF investment
Fund your children education via MF investment

Fund your children education via MF investment

Shashikant Singh Article rating: 3.5

As your child takes baby steps and gradually climbs his/her education ladder, you have ample time and option to plan the funding in advance via education loan or mutual fund investment. Read this to find out which one is better and why! 

RSS
First23112312231323142316231823192320Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR